-
Aurora vs. Canopy & Tilray: Which NASDAQ-Listed Cannabis Stock Offers The Best Growth Potential?
Thursday, November 7, 2024 - 11:15am | 594Aurora Cannabis Inc. (NASDAQ:ACB) recently reported strong quarterly earnings that outpaced market expectations, despite a downturn across the cannabis sector. Aurora's share price fell 18% following the earnings report, reflecting broader sector pressures, with the MSOS ETF down 29%. As of...
-
Sundial, Canopy Growth And More: Analyst Examines The Race For The US Cannabis Market
Sunday, September 10, 2023 - 12:48pm | 797US legal cannabis sales are predicted to exceed $28 billion in 2023, with promising regulatory developments such as the recommendation to "reschedule" cannabis by the HHS. Canada's cannabis exports have surged to C$160 million, a 50% increase year-on-year, and with new international...
-
Cronos Execs On Marijuana Legalization In Canada And How It Affects The Co: Market Could Be Ready To Go By 2019
Tuesday, March 21, 2017 - 1:40pm | 720In a recent chat with Cronos Group Inc (CVE: MJN) (OTC: PRMCF)’s President and CEO Michael Gorenstein, and its head of marketing and communications, Eric Klein, we looked into the challenges of exporting cannabis, recent corporate news, expansion plans and more. In this last piece, we’...
-
Cronos Group Execs Discuss The Challenges Of Exporting Cannabis As An Insurance-Reimbursed Product
Sunday, March 19, 2017 - 10:11pm | 1193Cronos Group Inc (CVE: MJN) (OTC: PRMCF) is one of the largest licensed cannabis producers in Canada, only trailing a few industry behemoths like CANOPY GROWTH CORP COM NPV (OTC: TWMJF), APHRIA INC COM NPV (OTC: APHQF) and AURORA CANNABIS IN COM NPV (OTCL ACBFF). A few days ago, Benzinga had the...
-
Cronos Group Execs Talk About Cannabis Co., Recent 'Bought Deal' And Expansion Plans
Saturday, March 18, 2017 - 6:28pm | 1581A few days ago, Benzinga had the chance to chat with Cronos Group Inc (CVE: MJN) (OTC: PRMCF)’s president and CEO Michael Gorenstein and its head of marketing and communications Eric Klein. The execs went into their business, the challenges of exporting cannabis, recent corporate news and...